Clinical Trial Update: First-in-Human (FIH) Study of the Xeltis Hemodialysis Access Graft [NA]

View source ↗

Summary

First-in-human study of the Xeltis Hemodialysis Access Graft is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Xeltis Hemodialysis Access Graft

Snippet

Sponsor: Xeltis | Conditions: End Stage Renal Disease, End Stage Renal Failure on Dialysis | NA | Status: ACTIVE_NOT_RECRUITING